# Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0

> **NCT03226431** · PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 6 (actual)

## Conditions studied

- Lung Transplant

## Interventions

- **DRUG:** Ascorbic Acid

## Key facts

- **NCT ID:** NCT03226431
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-11
- **Primary completion:** 2019-06-25
- **Final completion:** 2019-06-25
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03226431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03226431, "Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03226431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*